The expression of MYC in cancer cells or as a transduced factor during reprogramming supports this switch by inducing hypoxia inducible factor 1a (Hif1A) and its downstream targets pyruvate dehydrogenase kinase and other glycolytic enzymes (88–91). The gene discussed is MYC; the disease is cancer.